An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients

Table 1

The characteristics of the 173 hepatitis B virus- (HBV-) positive patients.

Age (years)	46 (25–79)
Gender (male/female)	96/77
AST (IU/L)	27 (11–269)
ALT (IU/L)	28 (7–680)
𝛾-GTP (IU/L)	25 (7–349)
ALP (IU/L)	203 (71–835)
Total bilirubin (mg/dL)	0.8 (0.1–2.3)
Albumin (g/dL)	3.90±0.40
Hemoglobin (g/dL)	13.5±3.8
Platelets (×10^3/𝜇L)	178±72
PT (%)	89.8±12.3
Diabetes mellitus (present/absent)	6/167
Glucose (mg/dL)	91.3±13.9
Triglyceride (mg/dL)	99.0±45.5
Total cholesterol (mg/dL)	177±32
Body mass index	22.9±4.1
HBV-DNA (logcopies/mL)	3.7 (n.d–over 9.1)*
HBe antigen (positive/negative)	59/114
Treatment with NAs (present/absent)	67/106
Histological stage of liver fibrosis (F0-1/F2/F3/F4)	94/38/28/13

n.d: not detectable; NAs: nucleoside/nucleotide analogues.
*HBV-DNA ranged from undetectable level in patients under treatment of NAs to over measurable level (9.1logcopies/mL) in patients without treatment.